Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
101.50
+3.63 (3.71%)
At close: Jul 30, 2026, 4:00 PM EDT
101.00
-0.50 (-0.49%)
After-hours: Jul 30, 2026, 7:54 PM EDT
Spyre Therapeutics Employees
Spyre Therapeutics had 112 employees as of March 31, 2026. The number of employees increased by 39 or 53.42% compared to the same quarter last year.
Employees
112
Change
39
Growth
53.42%
Revenue / Employee
n/a
Profits / Employee
-$1,327,705
Market Cap
8.93B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,402 |
| Crinetics Pharmaceuticals | 594 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Summit Therapeutics | 265 |
SYRE News
- 2 days ago - Spyre Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research - TheFly
- 17 days ago - Spyre Therapeutics price target raised to $120 from $84 at Mizuho - TheFly
- 4 weeks ago - Spyre Therapeutics Announces Grants of Inducement Awards - GlobeNewsWire
- 4 weeks ago - Spyre Therapeutics files automatic mixed securities shelf - TheFly
- 5 weeks ago - Biotech ETF Index Surges 10% After Rebalance - ETF Trends
- 5 weeks ago - Spyre Therapeutics price target raised to $135 from $115 at Deutsche Bank - TheFly
- 6 weeks ago - Spyre Therapeutics price target raised to $100 from $80 at Wedbush - TheFly
- 6 weeks ago - Spyre Therapeutics price target raised to $112 from $98 at BTIG - TheFly